Lobbying client · New York
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA)
8 lobbyists engaged · 30 registrations
See every filing in the registry →
Who it has engaged
| Lobbyist | Level | On | Compensation | Term |
|---|---|---|---|---|
| ALBANY STRATEGIC ADVISORS, LLC | State | Anticipate the $5,000 threshold will be exceeded | $7500 · Monthly | Mar 2026 – Dec 2026 |
| DICKINSON & AVELLA, PLLC | State | Anticipate the $5,000 threshold will be exceeded | $15833 · Monthly | Jan 2025 – Dec 2025 |
| DICKINSON & AVELLA, PLLC | State | Anticipate the $5,000 threshold will be exceeded | $15833 · Monthly | Jan 2023 – Dec 2023 |
| DICKINSON & AVELLA, PLLC. | State | Anticipate the $5,000 threshold will be exceeded | $15833 · Monthly | Jan 2023 – Dec 2023 |
| DISTINCTIVE PUBLIC AFFAIRS, LLC | State | Anticipate the $5,000 threshold will be exceeded | $11667 · Monthly | Jan 2025 – Dec 2025 |
| DISTINCTIVE PUBLIC AFFAIRS, LLC | State | Anticipate the $5,000 threshold will be exceeded | $11667 · Monthly | Jan 2024 – Dec 2024 |
| J STRATEGIES INC. | State | Anticipate the $5,000 threshold will be exceeded | $20833 · Monthly | Jan 2025 – Dec 2025 |
| J STRATEGIES INC. | State | Anticipate the $5,000 threshold will be exceeded | $20833 · Monthly | Jan 2023 – Dec 2023 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) | State | Anticipate the $5,000 threshold will be exceeded | $$5,000-6,000 · Range | Jan 2025 – Dec 2026 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) | State | Anticipate the $5,000 threshold will be exceeded | $$5,000-6,000 · Range | Jan 2023 – Dec 2024 |
| THE WRIGHT GROUP NY, INC. | State | Anticipate the $5,000 threshold will be exceeded | $6667 · Monthly | Jan 2023 – Mar 2023 |
| TRESS CAPITOL ADVISORS LLC | State | Anticipate the $5,000 threshold will be exceeded | $300000 · Anually | Jan 2025 – Dec 2025 |
| TRESS CAPITOL ADVISORS LLC | State | Anticipate the $5,000 threshold will be exceeded | $275000 · Anually | Jan 2023 – Dec 2023 |
Public record from the NY Ethics Commission (COELIG) and the NYC City Clerk. We publish it because it makes the influence landscape legible, not to imply that access can be bought.
